baber/WOPTO huggingface dataset:
Patent NZ-590613-A (NZ)
Title: Automatic injection device with trigger lock to control an internal syringe assembly
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/20
Filed: 2009-06-10
Abstract: 590613 Disclosed is an injection device which includes a housing adapted to receive a syringe with a discharge nozzle. The syringe is moveable in the housing on actuation of the injection device along a longitudinal axis from a retracted position in which the discharge nozzle is contained within the housing and an extended position in which the discharge nozzle of the syringe extends from the housing through an exit aperture. The injection device includes an actuator and a drive adapted to be acted upon by the actuator and in turn act upon the syringe to advance it from its retracted position to its extended position and discharge its contents through the discharge nozzle. The injection device has a locking mechanism moveable from an engaged position in a direction into the housing at the exit aperture into a disengaged position. The locking mechanism is adapted to prevent actuation of the device when it is in its engaged position and permit actuation of the device when it is in its disengaged position. The injection device has a syringe carrier for carrying the syringe as it is advanced and restraining its advancement beyond its extended position. The syringe carrier is adapted to support the syringe. The injection device includes a latch member adapted to prevent, in an engaged position of the locking mechanism, movement of the syringe carrier relative to the housing and further adapted to permit, in a disengaged position of the locking mechanism, the syringe carrier moving relative to the housing. The exit aperture is defined by a rim located on an edge of the housing. The locking mechanism comprises a contact surface which is adapted to extend over or around at least a part of the rim.
Patent NZ-592094-A (NZ)
Title: Antibodies that bind to il-18 and methods of purifying the same
Inventor: HICKMAN ROBERT K
IPC: C07K16/24
Filed: 2009-10-20
Abstract: Disclosed is a method for producing a host cell protein (HCP) reduced anti-interleukin-18 (IL-18) antibody, or antigen binding portion thereof, preparation from a sample mixture comprising an anti-IL-18 antibody, or antigen binding portion thereof, and at least one HCP, said method comprising: Subjecting said sample mixture to a reduction in pH thus forming a primary recovery sample, wherein said reduction in pH is between about 3.0 to about 4.0; Adjusting said primary recovery sample to a pH between about 4.5 to about 5.5 and a conductivity of approximately 9 mS per cm followed by; Applying said primary recovery sample to a cation exchange resin and collecting a cation exchange sample; and Applying said cation exchange sample to a hydrophobic interactive chromatography (HIC) resin and collecting an HIC sample, wherein said HIC sample comprises said HCP-reduced anti-IL-18 antibody, or antigen binding portion thereof, preparation.
Patent NZ-593477-A (NZ)
Title: Liquid metal ladle pipe automated transport and storage device
Inventor: BOISDEQUIN VINCENT
IPC: B22D11/106
Filed: 2009-11-19
Abstract: Disclosed is a device for transporting and storing at least one ladle shroud for a liquid metal casting plant, the ladle shroud having a channel through which liquid metal passes and extending along an axis, the device providing improved operational performance and safety to operators. The device includes a rack for storing the ladle shroud in a use position in which the axis of the channel is vertical, the rack providing an access from the outside to a lateral face of the shroud when the latter is in its use position. The device comprises a plurality of pins for cooperating with complementarily shaped notches in the shroud for immobilizing the shroud relative to the rack, the immobilizing means forming the means for positioning the shroud.
Patent NZ-600398-A (NZ)
Title: A combination pushbutton lock, wherein pressing a button causes a camming surface to engage one of a plurality of camming teeth, thereby rotating a lock wheel about a central axis of the button
Inventor: MEEKMA GLENN P
IPC: E05B37/16
Filed: 2010-12-07
Abstract: 600398 A combination pushbutton lock is disclosed. The lock includes a housing, a keypad disposed on the housing, and a latch (133) assembled with the housing. The keypad includes a plurality of button assemblies, each including an axially depressible button member including a camming surface, a lock wheel having a plurality of camming teeth, and a latch releasing feature secured to the lock wheel for rotation therewith. Pressing the button member causes the camming surface to engage one of the plurality of camming teeth, thereby incrementally rotating the lock wheel between a plurality of rotational positions. When the button members of a predetermined one or more of the plurality of button assemblies are depressed a predetermined number of times, the latch releasing features of each of the plurality of button assemblies align with a plurality of blocking features (137) of the latch to permit lateral sliding movement of the latch from a locked condition to an unlocked condition.
Patent NZ-615939-A (NZ)
Title: Compounds for use in the treatment of feline retroviral infections
Inventor: JUSTA NINA
IPC: A61P31/14
Filed: 2011-05-10
Abstract: The disclosure relates to 2,6-diaminopurine compounds of formula (I) and compositions thereof for use in the treatment or prevention of retroviral infections in felines, in particular cats, and to the use of the compounds and compositions for the treatment or prevention of feline leukemia virus (FeLV) infections occurring alone or together with feline immunodeficiency virus (FIV) infections in cats.
Patent NZ-618255-A (NZ)
Title: Unobtrusive nasal mask
Inventor: VON MOGER LOCHLAN
IPC: A61M16/06
Filed: 2010-06-02
Abstract: A patient interface for delivering breathable gas at a continuously positive pressure with respect to ambient air pressure to an entrance of a patient’s airways including at least an entrance of the patient’s nares, throughout the patient’s respiratory cycle, while the patient is sleeping, to ameliorate sleep disordered breathing, the patient interface comprising a sealing portion 210 including a nose tip engagement portion adapted to form a seal with the patient’s nose tip, an upper lip engagement portion adapted to form a seal with the patient’s upper lip and/or base of the patient’s nares, and nostril engagement flaps adapted to form a seal with the patient’s nares, headgear structured to maintain the sealing portion 210 in sealing contact with an area surrounding an entrance to the patient’s airways while maintaining said positive pressure at the entrance to the patient’s nares, and a plenum chamber 438 defined by a supporting wall and configured to be pressurized at said positive pressure. The nose tip engagement portion and the upper lip engagement portion are structured to extend or curve outwardly from the supporting wall. The nostril engagement flaps are cantilevered from the supporting wall so that the nostril engagement flaps flex outwardly away from each other when engaged with the patient’s nose. At least one of the headgear and the supporting wall is configured to limit the extent to which the nostril engagement flaps flex and prevents an angle between the nostril engagement flaps from reaching 180º
Patent NZ-622957-A (NZ)
Title: Method for the treatment of a liquid, in particular a mineral oil
Inventor: NUERK RUEDIGER UWE
IPC: C10G15/08
Filed: 2011-04-14
Abstract: Method for adjusting the operating point of a pressure wave generator (4) for treating a liquid, in particular mineral oil, with pressure waves of a first frequency for increasing the portion of low-boiling fractions in the liquid. The pressure wave generator (4) is communicated with a liquid via flowed-through pipings (5). The frequency of application of the pressure waves is varied and the operating point is determined as a point which results in a maximum in temperature rise of the liquid after passing the pressure wave generator (4) as a function of the frequency of application.
Patent NZ-627171-A (NZ)
Title: Transmucosal administration system for a pharmaceutical drug
Inventor: KRUMME MARKUS
IPC: A61K47/38
Filed: 2013-01-17
Abstract: The present disclosure relates to a transmucosai administration system to administer quinones, benzoquinones, and especially 1,4-benzoquinones, via the oromucosal route. The transmucosal administration system for a pharmaceutical active ingredient wherein the system contains a suspension comprising 30-60% by weight, of an active ingredient of the structural formula (I) and 40-70% by weight of a polyalcohol and/or a cellulose derivative as carrier material and wherein the system is a muco-adhesive film which dissolves in the mouth.
Patent NZ-629036-A (NZ)
Title: Veterinary compositions
Inventor: REPAKULA SREENATH
IPC: A61K9/00
Filed: 2011-02-15
Abstract: Disclosed is a controlled-release veterinary composition in a form of an orally deliverable tablet comprising: (a) at least one antibacterial bioactive agent for veterinary use; (b) a polymer having molecular weight from about 1,000,000 to about 9,000,000 daltons, or a polymer having a viscosity in a range of from about 80,000 to about 120,000 mPa.s, in an amount of about 5% to about 60% of the total weight of the tablet; and (c) at least one disintegrant agent in an amount between about 10% to about 50% of the total weight of the tablet. Also disclosed is the use of the composition to manufacture a composition used in treating dogs for pain, soft-tissue infections such as worms, allergic reactions and seizures. Preferable bioactive agents are aspirin, ibuprofen, ketoprofen, prednisolone, diclofenac sodium, deracoxib, diphendydramine, phenylbutazone, and N-methyl-1-{ trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl} methanesulfonamide. Preferred control release polymers are Hypromellose 2208 or high molecular weight (2,000,000 to 4,000,000 daltons) polyethylene oxides (Polyox WSR n-60).
Patent NZ-701527-A (NZ)
Title: Diagnostic gene marker panel for colorectal cancer
Inventor: MOLLOY PETER
IPC: C12Q1/68
Filed: 2013-05-10
Abstract: The present invention relates generally to an improved method of screening for the onset, predisposition to the onset and/or progression of a neoplasm which provides an improved level of sensitivity or specificity. More particularly, the present invention relates to a method of screening for the onset, predisposition to the onset and/or progression of a neoplasm by screening the methylation levels of two or more of the gene markers BCAT1, IKZF1, IRF4, GRASP and CAHM. Still more particularly, where two or more of the panel of gene markers exhibit increased methylation a high level of specificity is achieved while if only one of the two or more markers exhibits increased methylation then a high level of sensitivity is achieved. The method of the present invention is useful in a range of applications including, but not limited to, those relating to the diagnosis and/or monitoring of colorectal neoplasms, such as colorectal adenocarcinosis.
Patent NZ-707463-A (NZ)
Title: A claw for a milking machine
Inventor: LA TORRE CARLOS
IPC: A01J5/04
Filed: 2013-12-18
Abstract: A teat cup claw for a milking machine, with an ergonomic design, which provides improvements with regard to properties such as thickness, grip and observation of milk flow comprising an enclosure having an upper part (1) and a lower part (2) and enclosing an inner space (3) for a milk flow during a milking operation. The lower part comprises a bottom surface (4) facing the inner space. An outlet nipple (12), connected to a long milk conduit (13), extends outwardly from the upper part. A suction tube (20) connects the inner space to the outlet nipple, and comprises a lower tube section close to the bottom surface. Three support legs extend from the lower tube section and abut the bottom surface, thereby forming a gap between the lower tube section and the bottom surface. Each support leg has an end point, which end points are located in a common lower plane. The common lower plane is inclined to the centre axis.
Patent NZ-707550-A (NZ)
Title: Method for treating sepsis in patients with albumin, cholesterol and hdl levels above minimum thresholds
Inventor: LEVINE DANIEL M
IPC: A61P29/00
Filed: 2013-09-30
Abstract: The invention relates to the use of (i) a phospholipid, (ii) a neutral lipid, and (iii) a cholate salt in the manufacture of an emulsion for treating sepsis in a subject, wherein the subject has been screened to determine their level of serum albumin, total cholesterol and high density lipoprotein and wherein the medicament is formulated as an emulsion, and wherein the subject exhibits (a) a serum albumin level of at least 1.5 g/dL, and (b) one or both of a total cholesterol level of at least 40 mg/dL and a high density lipoprotein level of at least 20 mg/dL.
Patent NZ-708888-A (NZ)
Title: Easily dispersible formulations of pigments and their use in tinting base media
Inventor: SIMON FRANCIS ROBERT HINKLEY
IPC: C09D17/00
Filed: 2014-03-05
Abstract: Formulations of easily dispersible (ED) pigments comprising a combination of a carboxylic acid polymer and a non-ionic alkoxylated surfactant are disclosed. The combination is used in the formulation of a plurality of pigments. The formulations are suitable for mixing with a base medium at the point-of-sale (PoS) or by the end user.
Patent NZ-710173-A (NZ)
Title: Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
Inventor: DONELLO JOHN E
IPC: A61K31/4166
Filed: 2014-03-04
Abstract: The present invention relates to a method for treating ocular inflammatory diseases in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 such as compounds of Formula I and related structures.
Patent NZ-711802-A (NZ)
Title: Multicyclic compounds and methods of use thereof
Inventor: CAMPBELL JOHN EMMERSON
IPC: C07D495/04
Filed: 2010-12-03
Abstract: Disclosed are 7-aminoalkyl-thieno[2,3-c]pyran derivatives and analogues of formula (IVa) or a pharmaceutically acceptable salt or stereoisomer thereof, wherein (i) R1 and R3 together with the atoms to which they are attached form an optionally substituted heterocyclyl, and R4 is hydrogen or alkyl; or (ii) R3 and R4 together form a double bond and together with R1 and the atoms to which they are attached form an optionally substituted 5- to 20-membered heteroaryl; R2 is hydrogen, alkyl or absent; R5 is hydrogen or alkyl; R6 and R7 are each independently (i) hydrogen, halo, alkyl, alkoxyl, aminoalkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, or arylalkyl, each of which is optionally substituted; or (ii) -(CH2)p-R11, wherein R11 is CF3, CN, nitro, amino (-NH2), hydroxyl, cycloalkoxyl, heteroaryl, or heterocyclyl, each of which is optionally substituted; m is 0, 1, or 2; n is 0, 1, or 2; and each occurrence of p is independently 0, 1, or 2; and wherein the remaining substituents are as defined herein; wherein ‘cycloalkyl’ refers to a cyclic fully or partially saturated bridged and/or non-bridged hydrocarbon radical or ring system; and wherein ‘aminoalkyl’ refers to a stable straight or branched chain, or cyclic hydrocarbon radical, or combinations thereof having one or more N atoms. Representative compounds include 7-(R)-((2S)-pyrrolidin-2-yl)-4,6-dihydro-thieno[2,3-c]pyran, 7-(S)-((2S)-pyrrolidin-2-yl)-4,6-dihydro-thieno[2,3-c]pyran, 7-(R)-((2R)-pyrrolidin-2-yl)-4,6-dihydro-thieno[2,3-c]pyran, 7-(S)-((2R)-pyrrolidin-2-yl)-4,6-dihydro-thieno[2,3-c]pyran, 7-(S)-(imidazol-4-yl)-4,6-dihydro-thieno[2,3-c]pyran and 7-(2-methylpyrazol-3-yl)-4,6-dihydro-thieno[2,3-c]pyran. Also disclosed is a pharmaceutical composition comprising a compounds as defined above, and optionally further comprising one or more additional active agents, for treating a neurological disorder such as schizophrenia, psychotic disorders, Parkinson’s psychosis, Tourette’s syndrome, post-traumatic stress disorder, mood disorders, depression, bipolar disorder, obsessive compulsive disorder, narcolepsy, substance abuse or dependency, autism etc. etc..
Patent NZ-716708-A (NZ)
Title: Uniformly expandable stent
Inventor: CHANDUSZKO ANDRZEJ J
IPC: A61F2/82
Filed: 2013-03-12
Abstract: An intraluminal prosthesis includes a stent architecture having a series of stent elements repeating along a circumferential axis. One series of stent elements includes v-shaped stent elements having at least four different orientations, and V-shaped stent elements connecting adjacent v- shaped stent elements. One series of stent elements includes R-shaped stent elements having at least four different orientations, and U-shaped stent elements having at least two different orientations, the U-shaped stent elements connecting adjacent R-shaped stent elements. Adjacent series of stent elements can be connected by connectors. Portions of the stent elements may narrow in width along a length thereof. The stent architecture may include radiopaque element receiving members. The stent architecture may be formed by machining a metal or polymer tube. The intraluminal prosthesis may include one or more graft layers.
Patent NZ-723051-A (NZ)
Title: Pharmaceutical compounds
Inventor: BOYLE ROBERT
IPC: C07D403/12
Filed: 2015-02-09
Abstract: This invention relates to compounds of formula (0) that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.
Patent NZ-727351-A (NZ)
Title: Financial transaction system
Inventor: BRUCKNER MARTIN
IPC: G06Q40/02
Filed: 2015-05-21
Abstract: A financial transaction system providing a financial switching engine, the financial transaction system comprising: a distributed plurality of different physical data centres implemented at different respective physical locations, connected together via a private network; a plurality of plugins each configured to perform a different respective function of the financial transaction system; and an operating system on which the plugins run, the plugins being configured to communicate messages with one another in order to perform financial transactions; wherein the plugins are distributed amongst all of the data centres and the operating system is configured to abstract the plugins from the distributed data centres, wherein the financial switching engine is configured to examine content of said messages to determine a destination plugin to send the message to, such that the plugins communicate said messages with one another via the operating system without needing to specify particular ones of said data centres as destinations of the messages, while the operating system and financial switching engine handles routing of the messages between the data centres over the private network without the plugins needing visibility of the routing.
Patent NZ-728662-A (NZ)
Title: A process for purification of rhu-gcsf
Inventor: RAGHUWANSHI ARJUN
IPC: C12P21/00
Filed: 2015-07-13
Abstract: The present invention provides a scalable and industrially viable downstream process for purification of recombinant human G-CSF from inclusion bodies using cysteine in solubilisation buffer and cystine in the refolding buffer.
Patent NZ-734615-A (NZ)
Title: Solutions for enhancing the effectiveness of insecticides and fungicides on living plants and related methods
Inventor: WARD HANS A
IPC: C11D1/75
Filed: 2015-09-28
Abstract: The present invention relates to a solution for resisting destruction of living plants and a related method. Specifically the invention provides a solution for resisting destruction of living plants comprising: a buffered amine oxide administered admixed with at least one material selected from the group consisting of permethrin and propiconazole in water, the buffered amine oxide has a pH of 6.5 to 10.5 and is present in a concentration of 0.06% to 0.12% weight % and includes at least a 12 carbon length amine oxide (e.g. lauramine oxide), and said buffer system being selected from (a) potassium phosphate monobasic/potassium phosphate dibasic and (b) potassium bicarbonate/potassium carbonate. The solution provides a synergistically effective greater resistance to living plant deterioration than any of the individual buffered amine oxide, insecticides and fungicide achieve considered individually.
Patent NZ-737377-A (NZ)
Title: Apparatus and methods for sealing a vascular puncture
Inventor: HUNDERTMARK RONALD
IPC: A61M37/00
Filed: 2013-03-19
Abstract: An apparatus 10 for sealing an arteriotomy comprising a positioning assembly 14 having a proximal portion and a distal portion, a sealant 2 disposed at the distal portion of the positioning assembly 14, a support member 30 distally advanceable relative to the positioning assembly 14, and a positioning assembly retraction lock. The lock in a first position prevents retraction of the positioning assembly 14 relative to the support member 30. In a second position the lock permits retraction of at least a portion of the positioning assembly 14 relative to the support member 30 such that the support member 30 maintains the position of the sealant 2 during proximal movement of the positioning assembly 14 through the sealant. Distal advancement of the support member 30 moves the positioning assembly retraction lock to the second position.
Patent NZ-743320-A (NZ)
Title: Method for preparing polymeric micelle containing anionic drug
Inventor: NAM HYE YEONG
IPC: A61K9/107
Filed: 2016-12-16
Abstract: The present invention relates to a preparation method comprising the steps of: producing nanoparticles in an aqueous phase using electrostatic bonding between an anionic drug and a cationic compound, and incorporating the nanoparticles into a polymeric micelle consisting of an amphiphilic polymer and any polylactic acid salt, to thereby increase the yield for preparing a composition for delivering an anionic drug by raising the anionic drug inclusion rate of the formulation though the increase of electrostatic bonding and hydrophobic bonding.
Patent NZ-747763-A (NZ)
Title: Method and associated system for managing location information of an identification device
Inventor: TRACY AUSTIN
IPC: G06Q50/26
Filed: 2017-10-26
Abstract: A method for providing location information of an animal (7) wearing an identification device (5). The method is performed via a communication network (4) using a location system including a network server (1) and database (2). The database (2) contains identification information relating to identification devices (5) and associated animals (7) and contact information relating to at least one contact (6) associated with each identification device (5). The method includes receiving data from mobile devices (3), the data including identifiers of any proximal identification devices (5) - being identification devices within wireless signal range of the mobile devices (3), and receiving data including location information from the mobile devices (3). The method further includes determining a selected identification device (5) - being at least one of the proximal identification devices, the step of determining a selected identification device including: providing identification information to the mobile device (3), the identification information including at least one descriptor of an animal (7) associated with each proximal identification device (5), and receiving data from the mobile device (3) including a said identifier of the selected identification device (5).
Patent NZ-751202-A (NZ)
Title: Anti-pd-1 antibodies and their uses
Inventor: AFAR DANIEL E H
IPC: A61K39/395
Filed: 2017-09-14
Abstract: The present disclosure provides novel anti-PD-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.